H.R. 9635

Getting Innovations to Patients During Shutdowns Act

Sponsor: Kevin Mullin · 0 cosponsors

Where it stands

Referred to the House Committee on Energy and Commerce. (Jul 9)

No roll-call votes yet.

No official summary yet.

Sec. 1. Short title

Sec. 2. Special rules to provide for continued review of human drug and device submissions during a lapse of appropriations